
<h3>BIBLIOGRAFÍA</h3>

    <ol>
        <li>Castaman G, Linari S. Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders. J Clin Med 2017;10:6(4).</li>
		<li>Castaman G, Goodeve A, Eikenboom J; European Group on von Willebrand Disease. Principles of care for the diagnosis and treatment of von Willebrand disease. Haematologica 2013;98(5):667-74.</li>
		<li>Leebeek FWG, Eikenboom JCJ. Von Willebrand’s Disease. N Engl J Med 2016;375(21):2067-80.</li>
		<li>Batlle J, Pérez-Rodríguez A, Pinto JC, Batlle J, Pérez-Rodríguez A, Pinto JC, et al. Diagnosis and management of von Willebrand disease in Spain. Semin Thromb Hemost 2011;37(5):503-10.</li>
		<li>James AH, Eikenboom J, Federici AB. State of the art: von Willebrand disease. Haemophilia 2016;22(Suppl 5):54-9.</li>
		<li>Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG,Holmberg L, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006;4(10):2103-14.</li>
		<li>Batlle J, Pérez Rodríguez A, López Fernández MF. Classification of von Willebrand disease. In: Von Willebrand disease: Basic and clinical aspects. Ed. Federici A, Lee L, Berntorp E, Lillicrap D, Montgomery B. London: Wiley-Blackwell; 2011. p. 74-85.</li>
		<li>Rodeghiero F, Tosetto A. ISTH/SSC bleeding assessment tool: A standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010;8: 2063-5.</li>
		<li>Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003;15;101(6):2089-93.</li>
		<li>Bodó I, Eikenboom J, Montgomery R, Patzke J, Schneppenheim R, Di Paola J; von Willebrand factor Subcommittee of the Standardization and Scientific Committee of the International Society for Thrombosis and Haemostasis. Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH. J Thromb Haemost 2015;13(7):1345-50.</li>
		<li>Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, et al. Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm. Thromb Haemost 2016;115(1):40-50.</li>
<li>Corrales I, Catarino S, Ayats J, Arteta D, Altisent C, Parra R, et al. High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods. Haematologica 2012;97(7):1003-7.</li>
<li>Pérez A, Vidal F, Corrales I, et al. Enfermedad de von Willebrand. Capítulo 28. En: Manual de genética hematológica “GENHEM APP”-SEHH Manual de genética hematológica “GENHEM APP” - SEHH. Disponible en: <a href="http://www.sehh.es/es/" target="_blank">www.sehh.es/es/</a></li>
<li>Borrás N, Batlle J, Pérez-Rodríguez A, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, et al. Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Comprehensive genetic analysis by next-generation sequencing of 480 patients. Haematologica 2017 (en prensa). Disponible en: <a href="http://www.haematologica.org/content/haematol/early/2017/09/21/haematol.2017.168765.full.pdf" target="_blank">http://www.haematologica.org/content/haematol/early/2017/09/21/haematol.2017.168765.full.pdf</a></li>
<li>Batlle J, Pérez-Rodríguez A, Corrales I, Pinto JC, Fraga EL, Rodríguez-Trillo Tch A, et al. Diagnosis and management of von Willebrand disease in Spain. Annals of Blood 2017 (en prensa).</li> 
<li>Batlle J, Altisent C, Aznar JA, et al. Tratamiento de la enfermedad de Von Willebrand en España. Documento de consenso. Haematologica 2012; 97:1-23. Disponible en: <a href="http://www.seth.es" target="_blank">http://www.seth.es</a></li> 
<li>Laffan MA, Lester W, O’Donnell JS, Will A, Tait RC, Goodeve A, el al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 2014; 167(4):453-65.</li>
<li>Franchini M, Mannucci P. Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease. Expert Review of Hematology 2016. http://dx.doi.org/10.1080/17474086.2016.1214070</li>
<li>Singal M, Kouides PA. Recombinant von Willebrand factor: a first-of-its-kind product for von Willebrand disease. Drugs Today (Barc) 2016; 52:653-64.</li>
    </ol>